Literature DB >> 21846980

Programming of host metabolism by the gut microbiota.

Fredrik Bäckhed1.   

Abstract

The human gut harbors a vast ensemble of bacteria that has co-evolved with the human host and performs several important functions that affect our physiology and metabolism. The human gut is sterile at birth and is subsequently colonized with bacteria from the mother and the environment. The complexity of the gut microbiota is increased during childhood, and adult humans contain 150-fold more bacterial genes than human genes. Recent advances in next-generation sequencing technology and mechanistic testing in gnotobiotic mice have identified the gut microbiota as an environmental factor that contributes to obesity. Germ-free mice are protected against developing diet-induced obesity and the underlying mechanisms whereby the gut microbiota contributes to host metabolism are beginning to be clarified. The obese phenotype is associated with increased microbial fermentation and energy extraction; however, other microbially modulated mechanisms contribute to disease progression as well. The gut microbiota has profound effects on host gene expression in the enterohepatic system, including genes involved in immunity and metabolism. For example, the gut microbiota affects expression of secreted proteins in the gut, which modulate lipid metabolism in peripheral organs. In addition, the gut microbiota is also a source of proinflammatory molecules that augment adipose inflammation and macrophage recruitment by signaling through the innate immune system. TLRs (Toll-like receptors) are integral parts of the innate immune system and are expressed by both macrophages and epithelial cells. Activation of TLRs in macrophages dramatically impairs glucose homeostasis, whereas TLRs in the gut may alter the gut microbial composition that may have profound effects on host metabolism. Accordingly, reprogramming the gut microbiota, or its function, in early life may have beneficial effects on host metabolism later in life.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21846980     DOI: 10.1159/000328042

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  63 in total

Review 1.  Maternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review.

Authors:  Anne L Dunlop; Jennifer G Mulle; Erin P Ferranti; Sara Edwards; Alexis B Dunn; Elizabeth J Corwin
Journal:  Adv Neonatal Care       Date:  2015-12       Impact factor: 1.968

Review 2.  Progress and challenges in developing metabolic footprints from diet in human gut microbial cometabolism.

Authors:  Linda C Duffy; Daniel J Raiten; Van S Hubbard; Pamela Starke-Reed
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 3.  Gut microbiota: its role in hepatic encephalopathy.

Authors:  Rahul Rai; Vivek A Saraswat; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-16

Review 4.  The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?

Authors:  Giada De Palma; Stephen M Collins; Premysl Bercik; Elena F Verdu
Journal:  J Physiol       Date:  2014-04-22       Impact factor: 5.182

5.  Gut bacteria in health and disease.

Authors:  Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-09

Review 6.  Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome.

Authors:  Timothy G Dinan; John F Cryan
Journal:  Neuropsychopharmacology       Date:  2016-06-20       Impact factor: 7.853

Review 7.  The microbiota-gut-brain axis in functional gastrointestinal disorders.

Authors:  Giada De Palma; Stephen M Collins; Premysl Bercik
Journal:  Gut Microbes       Date:  2014-06-12

8.  Lipocalin 2 deficiency-induced gut microbiota dysbiosis evokes metabolic syndrome in aged mice.

Authors:  Vishal Singh; Sarah Galla; Rachel M Golonka; Andrew D Patterson; Benoit Chassaing; Bina Joe; Matam Vijay-Kumar
Journal:  Physiol Genomics       Date:  2020-07-06       Impact factor: 3.107

9.  Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism.

Authors:  Elodie Luche; Béatrice Cousin; Lucile Garidou; Matteo Serino; Aurélie Waget; Corinne Barreau; Mireille André; Philippe Valet; Michael Courtney; Louis Casteilla; Rémy Burcelin
Journal:  Mol Metab       Date:  2013-07-04       Impact factor: 7.422

Review 10.  Manipulating the Gut Microbiota: Methods and Challenges.

Authors:  Aaron C Ericsson; Craig L Franklin
Journal:  ILAR J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.